Core Viewpoint - IonQ's stock has experienced a significant decline, dropping 10.9% in January and an additional 23.9% in early February following a critical report from Wolfpack Research [1][2]. Financial Performance - IonQ's stock is down 23.9% from the end of trading last Friday through the close of Thursday's market session [1]. - The company reportedly lost funding for Pentagon contracts, which accounted for approximately 86% of its sales from 2022 through 2024 [2]. Critical Analysis - Wolfpack Research claims IonQ engaged in "serious shenanigans" regarding a $22 million deal with utility company EPB, suggesting the deal was exaggerated to create the appearance of a significant sale [3]. - The firm advises investors to sell IonQ stock while it is still performing relatively well [3]. Investor Sentiment - Despite the negative report, investors are encouraged to wait for IonQ's response and its upcoming fourth-quarter 2025 financial report before making any decisions [4]. - IonQ was not included in a list of the 10 best stocks to buy, as identified by the Motley Fool Stock Advisor analyst team [5].